Fierce Pharma16h
For struggling cell and gene therapy field, Peter Marks' FDA exit adds even more uncertainty
The sudden resignation of Peter Marks, M.D., Ph.D., from the FDA branch that regulates biological products for humans ...
How another firm's FDA approval could mean a big win for Denali Therapeutics
Key to 400-employee Denali's submission is the FDA allowing measurement of a type of GAG, called heparan sulfate, in ...
Is United Therapeutics Corporation (UTHR) The Most Profitable Biotech Stock To Buy Right Now?
We recently published a list of 7 Most Profitable Biotech Stocks To Buy Right Now. In this article, we are going to take a ...
Traws Pharma, Inc. (TRAW) Virtual Investor Event Transcript
Traws Pharma, Inc. ( NASDAQ: TRAW) Virtual Investor Event March 31, 2025 10:00 AM ET Werner Cautreels – Chief Executive Officer Robert Redfield – Chief Medical Officer David Pauza – Chief Science ...
United Therapeutics: Don't Fear The Patent Expiration Too Much
United Therapeutics has high revenue growth and low debt. Read why UTHR stock is undervalued with solid financial metrics and ...
S&P 500 Sinks 2% as Economic Fears Spur Bond Rally: Markets Wrap
Stocks got hammered, bonds climbed and gold hit a record high, following signs of weakness in the main engine of the US ...
Is Janux Therapeutics Inc. (NASDAQ:JANX) the Best Up and Coming Stock to Buy According to Wall Street Analysts?
We recently published a list of the 12 Best Up and Coming Stocks to Buy According to Wall Street Analysts. In this article, ...
3d Systems (DDD) Q4 2024 Earnings Call Transcript
Operator Greetings and welcome to the 3D Systems fourth quarter and fiscal year 2024 earnings conference call and webcast. At ...